Evaluating the Effect of Intravenous Laser and Comparison of Laser Treatment Effect with Red and Blue Wavelengths in the Treatment of Patients with Covid-19

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20111121008146N39

Enrollment

Registered

2022-08-02

Start date

2021-08-23

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 (Coronavirus Disease 2019). COVID-19, virus identified

Interventions

Intervention 1: Two case groups: The treatment procedure with a low-power gallium arsenide 660 nm laser diode with an output dose of 2 joules per square centimeter, continuous for 7 minutes 5 sessions

Eligibility

Sex/Gender

All

Age

30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Fever Cough Pneumonitis Positive PCR test Lung involvement>50% Taking any medication within the past month age between 30-80 year

Exclusion criteria

Exclusion criteria: Pregnancy Lactation Cardiovascular disease Hyper- and hypothyroidism Photosensitivity A history of seizure

Design outcomes

Primary

Measure	Time frame
Lung involvement on CT-scan. Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: CT-scanner.;IL-6 serum levels. Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: IL-6 ELISA kit.	—

Secondary

Measure	Time frame
Fever. Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Thermometer.;Oxygen saturation level. Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Pulse oxymeter.;PO2 (partial pressure of oxygen). Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: ABG (arterial-blood gas) test.;PCO2 (partial pressure of carbon dioxide). Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: ABG (arterial-blood gas) test.;Respiratory rate per minute. Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Counting the number of breaths in one minute.;WBC count. Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Patients' blood samples.;Platelet count. Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Patients' blood samples.;ESR (erthrocyte sedimentation rate). Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Patients' blood samples.;CRP (C-reactive protein). Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Patients' blood samples.	—

Measure

Time frame

Fever. Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Thermometer.;Oxygen saturation level. Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Pulse oxymeter.;PO2 (partial pressure of oxygen). Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: ABG (arterial-blood gas) test.;PCO2 (partial pressure of carbon dioxide). Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: ABG (arterial-blood gas) test.;Respiratory rate per minute. Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Counting the number of breaths in one minute.;WBC count. Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Patients' blood samples.;Platelet count. Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Patients' blood samples.;ESR (erthrocyte sedimentation rate). Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Patients' blood samples.;CRP (C-reactive protein). Timepoint: Before the intervention and after the last session of intravenous laser therapy. Method of measurement: Patients' blood samples.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Barati

Shahid Beheshti University of Medical Sciences

dr.baaraati@gmail.com+98 21 2271 8021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026